General Information of the Compound
| Compound ID |
CP0411746
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(10R,15S)-12-[3-(6-fluoro-2H-indazol-3-yl)propyl]-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-triene
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C24H28FN5
|
||||||||||||||||||
| Molecular Weight |
405.521
|
||||||||||||||||||
| Canonical SMILES |
CN1CCN2[C@H]3CCN(CCCc4n[nH]c5cc(F)ccc45)C[C@H]3c3cccc1c23
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C24H28FN5/c1-28-12-13-30-22-9-11-29(15-19(22)17-4-2-6-23(28)24(17)30)10-3-5-20-18-8-7-16(25)14-21(18)27-26-20/h2,4,6-8,14,19,22H,3,5,9-13,15H2,1H3,(H,26,27)/t19-,22-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
RSNYLBGZLKEOAP-UGKGYDQZSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00825, 5-hydroxytryptamine receptor 2A
Protein ID: PT00957, D(2) dopamine receptor